<br />
This is the Age of Patient Centricity, a<br />
landmark period where vital forces are sending seismic waves<br />
through healthcare and the pharmaceutical industry. The impera-<br />
tive to provide patients with much more than a pill or a potion has<br />
accelerated from a feel-good extra to a core DNA requirement<br />
which entwines medical, scientific, and technological advances<br />
with regulatory and commercial demands. Healthcare tech is<br />
pulsing with innovation across clinical trials, data collection, and<br />
connectivi-ty, enabling patients to have a more direct involvement<br />
and influence over the medicines that are developed for them. The<br />
advantages are clear: targeted treatments and focussed delivery<br />
systems that drive adher-ence, reduce wastage, and generate a<br />
financial dividend for healthcare systems creaking under the strain<br />
of ageing populations weighed down with comorbidit<a title="GOLD_01 page 1" href="https://secure.viewer.zmags.com/publication/e942c139?page=1"> This is the</a>
<a title="GOLD_01 page 2" href="https://secure.viewer.zmags.com/publication/e942c139?page=2"> </a>
<a title="GOLD_01 page 3" href="https://secure.viewer.zmags.com/publication/e942c139?page=3"> CEO’s LETTER I had an idea — to create a company</a>
<a title="GOLD_01 page 4" href="https://secure.viewer.zmags.com/publication/e942c139?page=4"> 4. NEWS In every issue we lo</a>
<a title="GOLD_01 page 5" href="https://secure.viewer.zmags.com/publication/e942c139?page=5"> NEWS L APPOINTMENTS T IGH AXOVANT APPOINTS AL</a>
<a title="GOLD_01 page 6" href="https://secure.viewer.zmags.com/publication/e942c139?page=6"> 6.TECH - eyeforpharma NOTABLE PARTNERSHIPS PFI</a>
<a title="GOLD_01 page 7" href="https://secure.viewer.zmags.com/publication/e942c139?page=7"> bettering them. This we can learn from them as we</a>
<a title="GOLD_01 page 8" href="https://secure.viewer.zmags.com/publication/e942c139?page=8"> 8.MEDICAL AFFAIRS </a>
<a title="GOLD_01 page 9" href="https://secure.viewer.zmags.com/publication/e942c139?page=9"> To address this challenge, pharma companies are r</a>
<a title="GOLD_01 page 10" href="https://secure.viewer.zmags.com/publication/e942c139?page=10"> 10.PATIENT CENTRICITY “Patients are, rightly s</a>
<a title="GOLD_01 page 11" href="https://secure.viewer.zmags.com/publication/e942c139?page=11"> PATIENT CENTRICITY This is the Age of Patien</a>
<a title="GOLD_01 page 12" href="https://secure.viewer.zmags.com/publication/e942c139?page=12"> 12.PATIENT CENTRICITY Craig Mills, Managing D</a>
<a title="GOLD_01 page 13" href="https://secure.viewer.zmags.com/publication/e942c139?page=13"> RUNNING HEAD 13.</a>
<a title="GOLD_01 page 14" href="https://secure.viewer.zmags.com/publication/e942c139?page=14"> 14.MEDICAL AFFAIRS - eyeforpharma l </a>
<a title="GOLD_01 page 15" href="https://secure.viewer.zmags.com/publication/e942c139?page=15"> Therefore, it is crucial to consider the endpoint</a>
<a title="GOLD_01 page 16" href="https://secure.viewer.zmags.com/publication/e942c139?page=16"> PHARMA </a>
<a title="GOLD_01 page 17" href="https://secure.viewer.zmags.com/publication/e942c139?page=17"> (in 扩llions $) 2017 2016 </a>
<a title="GOLD_01 page 18" href="https://secure.viewer.zmags.com/publication/e942c139?page=18"> 18. DIGITAL REQUEST TECH The future of the</a>
<a title="GOLD_01 page 19" href="https://secure.viewer.zmags.com/publication/e942c139?page=19"> TECH 19. DIGITAL STATS By 2022, the adoption </a>
<a title="GOLD_01 page 20" href="https://secure.viewer.zmags.com/publication/e942c139?page=20"> 20.INTERVIEW CATALYSTS OF PHARMA </a>
<a title="GOLD_01 page 21" href="https://secure.viewer.zmags.com/publication/e942c139?page=21"> INTERVIEW Your talk at eyeforpharma, Barcelon</a>
<a title="GOLD_01 page 22" href="https://secure.viewer.zmags.com/publication/e942c139?page=22"> 22. MARKETING eyeforpharma REDEFINING THE </a>
<a title="GOLD_01 page 23" href="https://secure.viewer.zmags.com/publication/e942c139?page=23"> eyeforpharma - MARKETING 23. Existing</a>
<a title="GOLD_01 page 24" href="https://secure.viewer.zmags.com/publication/e942c139?page=24"> 24.NEWS SP ON FULL OF TECH </a>
<a title="GOLD_01 page 25" href="https://secure.viewer.zmags.com/publication/e942c139?page=25"> TECH 25. HIGH ALERT FOR PHARMA AS CYBER GANG</a>
<a title="GOLD_01 page 26" href="https://secure.viewer.zmags.com/publication/e942c139?page=26"> 26.DIVERSITY “Senior female executives still </a>
<a title="GOLD_01 page 27" href="https://secure.viewer.zmags.com/publication/e942c139?page=27"> “Women make more than 80% of ĩĈÝńƇĩûÝŸĈāĈûĭžĭŕōžɕ</a>
<a title="GOLD_01 page 28" href="https://secure.viewer.zmags.com/publication/e942c139?page=28"> 28.MARKETING REACHING PHARMA STAKEHOLDERS WORDS </a>
<a title="GOLD_01 page 29" href="https://secure.viewer.zmags.com/publication/e942c139?page=29"> MARKETING “Media training can help to ident</a>
<a title="GOLD_01 page 30" href="https://secure.viewer.zmags.com/publication/e942c139?page=30"> 30.MEDICAL AFFAIRS + MARKETING “Regulatory</a>
<a title="GOLD_01 page 31" href="https://secure.viewer.zmags.com/publication/e942c139?page=31"> MEDICAL AFFAIRS + MARKETING “To deliver </a>
<a title="GOLD_01 page 32" href="https://secure.viewer.zmags.com/publication/e942c139?page=32"> 32.PATIENT CENTRICITY - eyeforpharma SOMEWHERE B</a>
<a title="GOLD_01 page 33" href="https://secure.viewer.zmags.com/publication/e942c139?page=33"> as a study subject and see them as a true researc</a>
<a title="GOLD_01 page 34" href="https://secure.viewer.zmags.com/publication/e942c139?page=34"> </a>
<a title="GOLD_01 page 35" href="https://secure.viewer.zmags.com/publication/e942c139?page=35"> MARKETING 35. GIVING MARKET ACCESS A MAK V </a>
<a title="GOLD_01 page 36" href="https://secure.viewer.zmags.com/publication/e942c139?page=36"> we speak patient Immersing our clients and their </a>